Sana Biotechnology Releases Updated Corporate Presentation (Sep 8, 2026)

What Happened
Sana Biotechnology, Inc. (SANA) filed a Current Report on Form 8-K on September 8, 2026 (Item 7.01) disclosing that it released an updated corporate presentation. The company said it intends to use and discuss this Corporate Presentation at upcoming investor conferences. The presentation is furnished as Exhibit 99.1 to the 8-K.

Key Details

• Filing date: September 8, 2026 (Form 8-K).
• Disclosure type: Regulation FD Disclosure reported under Item 7.01.
• Exhibit furnished: Corporate Presentation dated September 8, 2026 (Exhibit 99.1).
• Interactive data cover page included as Exhibit 104 (Inline XBRL).

Why It Matters
This filing makes Sana’s current investor presentation publicly available so all investors have equal access to the company’s messaging ahead of investor conferences. Review of Exhibit 99.1 will show the specific slides and corporate updates Sana plans to present; because this is a Regulation FD disclosure, it signals the company is publicly sharing that material information rather than communicating it selectively.